Abstract
EBV-transformed lymphoblastoid cell lines (LCLs) are used as a resource for human genetic, immunological, and pharmacogenomic studies. We investigated the biological activity of 20 LCL strains during continuous long-term subculture up to a passage number of 160. Out of 20 LCL strains, 17 proliferated up to a passage number of 160, at which point LCLs are generally considered as “immortalized”. The other three LCL strains lost the ability to proliferate at an average passage number of 41, during which these LCLs may have undergone cellular crisis. These non-immortal LCL strains exhibited no telomerase activity, decreased EBV gene expression, and a lower copy number of the EBV genome and mitochondrial DNA when compared with immortal LCLs. Thus, this study suggests that sustained EBV viral activity as well as telomerase activity may be required for complete LCL immortalization.
Similar content being viewed by others
References
Belair, C.D., Yeager, T.R., Lopez, P.M., and Reznikoff, C.A (1997). Telomerase activity: A biomarker of cell proliferation, not malignant transformation. Proc. Natl. Acad. Sci. USA 94, 13677–13682.
Cahir-McFarland, E.D., Carter, K., Rosenwald, A., Giltnane, J.M., Henrickson, S.E., Staudt, L.M., and Kieff, E. (2004). Role of NF-{kappa}B in cell survival and transcription of latent membrane protein 1-expressing or epstein-Barr virus latency III-infected Cells. J. Virol. 78, 4108–4119.
Carter, K.L., Cahir-McFarland, E., and Kieff, E. (2002). Epstein-Barr virus-induced changes in B-lymphocyte gene expression. J. Virol. 76, 10427–10436.
Cooper, A, Johannsen, E., Maruo, S., Cahir-McFarland, E., Illanes, D., Davidson, D., and Kieff, E. (2003). EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth. J. Virol. 77, 999–1010.
Eliopoulos, A.G., and Young, L.S. (2001). LMP1 structure and signal transduction. Semin. Cancer Biol. 11, 435–144.
Grimm, T., Schneider, S., Naschberger, E., Huber, J., Guenzi, E., Kieser, A., Reitmeir, P., Schulz, T.F., Morris, C.A., and Stürzl, M. (2005). EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX. Blood 105, 3263–3269.
Hahn, W.C. (2002). Immortalization and transformation of human cells. Mol. Cells 13, 351–361.
Hei, T.K., Persaud, R., Zhou, H., and Suzuki, M. (2004) Genotoxicity in eyes of bystander cells. Mutat. Res. 568, 111–120.
Henkel, T., Ling, P.D., Hayward, S.D., and Peterson M.G. (1994). Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa, Science 265, 92–95.
Hur, D.Y., Lee, M.H., Kim, J.W., Kim, J.H., Shin, Y.K, Rho. J.K., Kwack, K.B., Lee, W.J., and Han, B.G. (2005). CD19 signalling improves the Epstein-Barr virus-induced immortalization of human B cell. Cell Prolif. 38, 35–45.
Jeon, J.P., Shim, S.M., Nam, H.Y., Baik, S.Y., Kim. J.W., and Han, B.G. (2007). Copy number increase of 1p36.33 and mitochondrial genome amplification in Epstein-Barr virus-transformed lymphoblastoid cell lines. Cancer Genet. Cytogenet. 173, 122–130.
Jeon, J.P., Kim, J.W., Park, B., Nam, H.Y., Shim, S.M., Lee, M.H., and Han, B.G.. (2008) Identification of tumor necrosis factor signaling-related proteins during Epstein-Barr virus-induced B cell transformation. Acta Virologica 52, 151–159.
Johannsen, E., Koh, E., Mosialos, G., Tong, X., Kieff, E., and Grossman, S.R. (1995). Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. J. Virol. 69, 253–262.
Johannsen, E., Miller, C.L, Grossman, S.R., and Kieff, E. (1996). EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes. J. Virol. 70, 4179–4183.
Kamranvar, S.A., Gruhne, B., Szeles, A, and Masucci, M.G. (2007). Epstein-Barr virus promotes genomic instability in Burkitt’s lymphoma. Oncogene 26, 5115–5123.
Kieff, E., and Rickinson, A.B. (2001). In Fields Virology, D.M. Knipe, and P.M. Howley, eds. (Lippincott, Philadelphia, USA). Vol. 2, pp. 2511–2628.
Kilger, E., Kieser, A., Baumann, M., and Hammerschmidt, W. (1998). Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17, 1700–1709.
Kim, K.J., Lee, H.J., Park, M.H., Cha, S.H., Kim, K.S., Kim, H.T., Kimm, K., Oh, B., and Lee, J.Y. (2006). SNP identification, link-age disequilibrium, and haplotype analysis for a 200-kb genomic region in a Korean population. Genomics 88, 535–540.
Liu, J.P., Cassar, L, Pinto, A, and Li, H. (2006). Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma. Cell Res. 16, 809–817.
McClain, K., Estrov, Z., Raju, U., Kelley, P.K., and Aggarwal, B.B. (1997). Epstein-Barr virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes. Methods 11, 83–87.
Mei, Y.P., Zhu, X.F., Zhou, J.M., Huang, H., Deng, R., and Zeng, Y.X. (2006). siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression. Cancer Lett. 232, 189–198.
Mochida, A, Gotoh, E., Senpuku, H., Harada, S., Kitamura, R., Takahashi, T., and Yanagi, K. (2005). Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt’s lymphoma cell lines. Arch. Virol. 150, 2139–2150
Redon, R., Ishikawa, S., Fitch, K.R., Feuk, L., Perry, G.H., Andrews, T.D., Fiegler, H., Shapero, M.H., Carson, A.R., Chen, W., et al. (2006). Global variation in copy number in the human genome. Nature 444, 444–454.
Robertson, E.S., Lin, J., and Kieff, E. (1996). The ami no-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). J. Virol. 70, 3068–3074.
Rodriguez-Revenga, L., Mila, M., Rosenberg, C., Lamb, A., and Lee, C. (2007). Structural variation in the human genome: the impact of copy number variants on clinical diagnosis. Genet. Med. 9, 600–606.
Saito, N., Courtois, G., Chiba, A., Yamamoto, N., Nitta, T., Hironaka, N., Rowe, M., Yamamoto, N., and Yamaoka, S. (2003). Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-{kappa}B through distinct signaling pathways in fibroblast cell lines. J. Biol. Chem. 278, 46565–46575.
Shimizu, N., Tanabe-Tochikura, A., Kuroiwa, Y., and Takada, K. (1994). Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitfs lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J. Virol. 68, 6069–6073.
Spender, L.C., Cornish, G.H., Sullivan, A, and Farrell, P.J. (2002). Expression of transcription factor AML-2 (RUNX3, CBFalpha-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. J. Virol. 76, 4919–4927.
Srinivas, S.K., and Sixbey, J.W. (1995). Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2. J. Virol. 69, 8155–8158.
Sugimoto, M., Furuichi, Y., Ide, T., and Goto, M. (1999). Incorrect us of “immortalization” for B-lymphoblastoid cell lines transformed by Epstein-Barr virus. J. Virol. 73, 9690–9691.
Sugimoto, M., Tahara, H., Ide, T., and Furuichi, Y. (2004). Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res. 64, 3361–3364.
Sylla, B.S., Hung, S.C., Davidson, D.M., Hatzivassiliou, E., Malinin, N.L., Wallach, D., Gilmore, T.D., Kieff, E., and Mosialos, G. (1998). Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta. Proc. Natl. Acad. Sci. USA 95, 10106–10111.
Toda, T., and Sugimoto, M. (2003). Proteome analysis of Epstein-Barr virus-transformed B-lymphoblasts and the proteome data-base. J. Chromatography B. 787, 197–206.
Yoo, Y.K., Ke, X., Hong, S., Jang, H.Y., Park, K., Kim, S., Ahn, T., Lee, Y.D., Song, O., Rho, N.Y., et al. (2006). Fine-scale map of encyclopedia of DNA elements regions in the Korean population. Genetics 774, 491–497.
Young, L.S., and Rickinson, A.B. (2004). Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4, 757–768.
Zhang, L, Hong, K, Zhang, J., and Pagano, J.S. (2004). Multiple signal transducers and activators of transcription are induced by EBV LMP-1. Virology 323, 141–152.
Zhao, B., Maruo, S., Cooper, A., Chase, M.R., Johannsen, E., Kieff, E., and Cahir-McFarland, E. (2006). RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc. Natl. Acad. Sci. USA 103, 1900–1905.
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
About this article
Cite this article
Jeon, JP., Nam, HY., Shim, SM. et al. Sustained viral activity of epstein-Barr virus contributes to cellular immortalization of lymphoblastoid cell lines. Mol Cells 27, 143–148 (2009). https://doi.org/10.1007/s10059-009-0018-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-009-0018-y